Multicare Health System
Multicare Health System was paid $46.65M by Medicaid between Mar 2018 and Dec 2024, across 327 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 33% of everything it billed.
33Billing provider infoMULTICARE HEALTH SYSTEM
SPOKANE, WA 99202
SPOKANE, WA 99202
33aNPI1730687161assigned 01/31/2018
33bProvider typeChiropractor
28Total paid$46.65M
24GClaims933,187
24DCodes billed327
24AFirst – last monthMar 2018 – Dec 2024
Compared with peers
Next to other Chiropractor providers in Washington
Rank by total paid#1 of 48
Median peer was paid$7K
This provider vs. median6,572×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 113,878 | $5.70M | |
| 2019 | 144,821 | $7.12M | |
| 2020 | 116,210 | $5.17M | |
| 2021 | 160,571 | $7.10M | |
| 2022 | 130,561 | $7.59M | |
| 2023 | 129,651 | $7.49M | |
| 2024incomplete | 137,495 | $6.47M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 33% | 225,383 | 210,682 | $15.51M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 19% | 158,277 | 150,153 | $8.76M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 3.9% | 19,069 | 17,814 | $1.83M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.6% | 17,386 | 17,254 | $1.68M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.6% | 18,408 | 17,065 | $1.66M |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 3.1% | 2,131 | 1,639 | $1.45M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.0% | 14,555 | 14,469 | $1.39M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.6% | 38,426 | 15,331 | $1.20M |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 1.9% | 9,883 | 9,487 | $897K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 1.9% | 23,628 | 9,400 | $885K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.7% | 7,394 | 7,275 | $794K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.3% | 8,424 | 8,294 | $625K |
315 more codes
| J0178 | Injection, aflibercept, 1 mg | 1.2% | 442 | $563K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | 1.1% | 9,979 | $526K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.1% | 5,097 | $522K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 1.1% | 4,150 | $495K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 6,716 | $416K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 18,404 | $396K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 5,386 | $389K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 1,933 | $273K |
| 99223 | Prolong inpt eval add15 m | <1% | 2,440 | $246K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 4,171 | $221K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 3,554 | $211K |
| 90686 | <1% | 15,877 | $210K | |
| 97803 | <1% | 4,055 | $194K | |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 3,225 | $191K |
| 95886 | <1% | 1,654 | $173K | |
| 92015 | Determination of refractive state | <1% | 17,334 | $173K |
| 80305 | <1% | 14,154 | $161K | |
| 64615 | <1% | 1,632 | $148K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 4,490 | $145K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 1,460 | $131K |
| 92134 | <1% | 6,158 | $122K | |
| 64402 | <1% | 863 | $117K | |
| J9035 | Injection, bevacizumab, 10 mg | <1% | 1,563 | $115K |
| 90670 | <1% | 8,670 | $108K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 2,704 | $106K |
| 20611 | <1% | 2,074 | $105K | |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 2,421 | $103K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 2,841 | $92K |
| 31231 | <1% | 660 | $91K | |
| 95806 | <1% | 2,519 | $87K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 1,207 | $86K |
| 99499 | <1% | 3,083 | $85K | |
| 95951 | <1% | 508 | $79K | |
| 92557 | <1% | 2,833 | $75K | |
| V2799 | Vision item or service, miscellaneous | <1% | 799 | $72K |
| 36415 | Collection of venous blood by venipuncture | <1% | 22,810 | $72K |
| 99205 | Prolong outpt/office vis | <1% | 514 | $71K |
| 80053 | Comprehensive metabolic panel | <1% | 7,773 | $62K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 1,155 | $59K |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 886 | $59K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 9,271 | $59K |
| 97597 | <1% | 4,089 | $58K | |
| 64400 | <1% | 814 | $56K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,052 | $52K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 7,883 | $52K |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | <1% | 4,332 | $50K |
| 90680 | <1% | 4,042 | $49K | |
| 64721 | <1% | 180 | $49K | |
| 92567 | <1% | 4,098 | $48K | |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 2,383 | $48K |
| 99429 | <1% | 3,235 | $46K | |
| 64505 | <1% | 791 | $44K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,234 | $44K |
| 0012A | <1% | 1,022 | $40K | |
| 64405 | <1% | 896 | $40K | |
| 96127 | <1% | 6,242 | $39K | |
| 90647 | <1% | 3,237 | $39K | |
| 11750 | <1% | 390 | $38K | |
| 80061 | Lipid panel | <1% | 3,936 | $36K |
| 90723 | <1% | 2,899 | $36K | |
| 94729 | <1% | 1,245 | $35K | |
| 90633 | <1% | 2,803 | $34K | |
| 64450 | <1% | 855 | $33K | |
| 0011A | <1% | 1,189 | $32K | |
| 20553 | <1% | 1,276 | $32K | |
| 94726 | <1% | 1,118 | $30K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 874 | $29K |
| 94060 | <1% | 1,217 | $27K | |
| 90837 | Psychotherapy session, about an hour | <1% | 304 | $26K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,469 | $26K |
| 90961 | <1% | 926 | $24K | |
| 95819 | <1% | 614 | $24K | |
| 95913 | <1% | 122 | $24K | |
| 80050 | General health panel | <1% | 895 | $23K |
| 77014 | <1% | 351 | $22K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,492 | $22K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,051 | $22K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 5,305 | $21K |
| 97161 | <1% | 340 | $21K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 177 | $21K |
| 90677 | <1% | 1,252 | $21K | |
| 99381 | <1% | 244 | $20K | |
| 95251 | <1% | 1,052 | $19K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,383 | $19K |
| 90651 | <1% | 1,429 | $19K | |
| 99188 | <1% | 1,531 | $18K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 137 | $17K |
| 99354 | <1% | 198 | $17K | |
| 90697 | <1% | 1,030 | $16K | |
| 77427 | <1% | 164 | $16K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,562 | $15K |
| 82607 | <1% | 1,241 | $15K | |
| 90688 | <1% | 1,212 | $14K | |
| 69210 | <1% | 566 | $14K | |
| 95720 | <1% | 152 | $14K | |
| 0001A | <1% | 319 | $13K | |
| 95811 | <1% | 216 | $13K | |
| 86803 | <1% | 1,029 | $13K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,191 | $13K |
| 90698 | <1% | 1,171 | $13K | |
| 95910 | <1% | 110 | $12K | |
| 82728 | <1% | 1,139 | $12K | |
| 92579 | <1% | 337 | $12K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 725 | $12K |
| 86780 | <1% | 1,001 | $12K | |
| 97162 | <1% | 186 | $12K | |
| 11102 | <1% | 165 | $11K | |
| 76942 | <1% | 357 | $11K | |
| 71250 | <1% | 375 | $10K | |
| 90935 | Hemodialysis procedure with single evaluation by a physician | <1% | 498 | $10K |
| 90656 | <1% | 1,283 | $10K | |
| 73630 | <1% | 891 | $10K | |
| 0002A | <1% | 240 | $10K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 103 | $10K |
| 82746 | <1% | 774 | $9K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 89 | $9K |
| 52000 | <1% | 82 | $8K | |
| 95912 | <1% | 54 | $8K | |
| 83550 | <1% | 1,167 | $8K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 131 | $8K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,166 | $8K |
| D0120 | Dental checkup, returning patient | <1% | 309 | $7K |
| 95909 | <1% | 76 | $7K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 57 | $7K |
| 90962 | <1% | 473 | $7K | |
| 84439 | <1% | 941 | $7K | |
| 90710 | <1% | 648 | $7K | |
| 99245 | <1% | 48 | $7K | |
| 31575 | <1% | 98 | $7K | |
| 83970 | <1% | 245 | $7K | |
| 90685 | <1% | 524 | $7K | |
| 43248 | <1% | 92 | $7K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 219 | $7K |
| 85027 | <1% | 1,314 | $7K | |
| 17110 | <1% | 96 | $7K | |
| 82570 | <1% | 1,759 | $6K | |
| 90674 | <1% | 219 | $6K | |
| 47562 | <1% | 12 | $6K | |
| 82962 | <1% | 3,129 | $6K | |
| 83540 | <1% | 1,225 | $6K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 410 | $6K |
| 93000 | <1% | 899 | $6K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 608 | $6K |
| 85610 | <1% | 2,868 | $6K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 177 | $6K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 208 | $6K |
| 11100 | <1% | 82 | $5K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 60 | $5K |
| 97014 | <1% | 598 | $5K | |
| D9999 | Unspecified adjunctive procedure, by report | <1% | 222 | $5K |
| D1206 | Topical application of fluoride varnish | <1% | 239 | $5K |
| 82043 | <1% | 1,286 | $5K | |
| 77334 | <1% | 65 | $5K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 57 | $5K |
| 81002 | <1% | 1,714 | $5K | |
| 90715 | <1% | 320 | $5K | |
| 95812 | <1% | 29 | $5K | |
| 95885 | <1% | 69 | $5K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 58 | $5K |
| 99254 | <1% | 39 | $5K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 28 | $4K |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) | <1% | 101 | $4K |
| 87340 | <1% | 476 | $4K | |
| 99443 | <1% | 113 | $4K | |
| 51798 | <1% | 760 | $4K | |
| 0071A | <1% | 103 | $4K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 26 | $4K |
| 97802 | <1% | 39 | $4K | |
| 59025 | Fetal non-stress test | <1% | 98 | $4K |
| 90480 | <1% | 112 | $4K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 314 | $4K |
| 90744 | <1% | 418 | $4K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 88 | $4K |
| 80076 | <1% | 461 | $4K | |
| 90648 | <1% | 341 | $4K | |
| 20610 | <1% | 122 | $3K | |
| 99173 | <1% | 1,925 | $3K | |
| 92202 | <1% | 392 | $3K | |
| 90734 | <1% | 328 | $3K | |
| 0072A | <1% | 78 | $3K | |
| 17250 | <1% | 168 | $3K | |
| 90756 | <1% | 207 | $3K | |
| 99201 | <1% | 95 | $3K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 822 | $3K |
| 92310 | <1% | 104 | $3K | |
| 92582 | <1% | 49 | $3K | |
| 77336 | <1% | 64 | $3K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 268 | $3K |
| 90672 | <1% | 153 | $3K | |
| 97598 | <1% | 56 | $2K | |
| 86140 | <1% | 559 | $2K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 66 | $2K |
| 31579 | <1% | 14 | $2K | |
| 99421 | <1% | 242 | $2K | |
| 83735 | <1% | 409 | $2K | |
| 81025 | <1% | 277 | $2K | |
| 92504 | <1% | 96 | $2K | |
| 92556 | <1% | 64 | $2K | |
| 77263 | <1% | 27 | $2K | |
| 99253 | <1% | 27 | $2K | |
| J7999 | Compounded drug, not otherwise classified | <1% | 527 | $2K |
| 80047 | <1% | 166 | $2K | |
| 87081 | <1% | 272 | $2K | |
| 70210 | <1% | 138 | $2K | |
| 73564 | <1% | 149 | $2K | |
| 99442 | <1% | 54 | $2K | |
| 92550 | <1% | 100 | $2K | |
| 97165 | <1% | 25 | $2K | |
| 90619 | <1% | 155 | $2K | |
| 73610 | <1% | 131 | $2K | |
| 84481 | <1% | 90 | $2K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 13 | $2K |
| 90700 | <1% | 119 | $2K | |
| 54150 | <1% | 37 | $2K | |
| 85007 | <1% | 553 | $2K | |
| 96161 | <1% | 634 | $1K | |
| 84153 | <1% | 148 | $1K | |
| 99221 | <1% | 24 | $1K | |
| 90732 | <1% | 12 | $1K | |
| 90696 | <1% | 126 | $1K | |
| 99243 | <1% | 15 | $1K | |
| 81001 | <1% | 591 | $1K | |
| 73110 | <1% | 107 | $1K | |
| 93018 | <1% | 193 | $1K | |
| 98968 | <1% | 34 | $1K | |
| 82310 | <1% | 232 | $1K | |
| 85652 | <1% | 563 | $1K | |
| 93016 | <1% | 150 | $1K | |
| 80069 | <1% | 197 | $1K | |
| 90707 | <1% | 101 | $1K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 25 | $1K |
| 90716 | <1% | 82 | $1K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 15 | $1K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 29 | $1K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 41 | $962.51 |
| 76536 | <1% | 29 | $931.94 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 237 | $927.29 |
| 93295 | <1% | 70 | $925.66 | |
| 73130 | <1% | 77 | $913.81 | |
| 76801 | <1% | 14 | $908.90 | |
| 99441 | <1% | 85 | $896.24 | |
| 97035 | <1% | 81 | $896.16 | |
| 95813 | <1% | 15 | $887.58 | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 17 | $875.84 |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 25 | $853.04 |
| 73030 | <1% | 111 | $742.44 | |
| 92133 | <1% | 27 | $713.67 | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 12 | $699.79 |
| 93296 | <1% | 132 | $693.69 | |
| 84156 | <1% | 230 | $680.63 | |
| 11721 | <1% | 44 | $673.91 | |
| 86756 | <1% | 44 | $657.99 | |
| 20552 | <1% | 16 | $651.35 | |
| 92588 | <1% | 25 | $603.05 | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 14 | $560.98 |
| 0082A | <1% | 13 | $542.00 | |
| 82784 | <1% | 98 | $508.29 | |
| 0073A | <1% | 12 | $502.00 | |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | <1% | 87 | $474.50 |
| 92060 | <1% | 13 | $455.40 | |
| 84403 | <1% | 24 | $452.56 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 189 | $418.58 |
| 96367 | <1% | 17 | $392.48 | |
| 81003 | <1% | 228 | $382.49 | |
| 72100 | <1% | 42 | $370.36 | |
| 84550 | <1% | 118 | $366.56 | |
| 86703 | <1% | 26 | $327.02 | |
| 82950 | <1% | 75 | $319.86 | |
| 94010 | <1% | 23 | $317.56 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 36 | $306.87 |
| 92136 | <1% | 13 | $287.40 | |
| 91319 | <1% | 15 | $282.77 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 727 | $280.07 |
| Q4010 | Cast supplies, short arm cast, adult (11 years +), fiberglass | <1% | 14 | $261.64 |
| 95970 | <1% | 13 | $254.91 | |
| 86706 | <1% | 25 | $244.26 | |
| 73502 | <1% | 54 | $242.80 | |
| 83001 | <1% | 14 | $232.99 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 25 | $218.00 |
| 84702 | <1% | 15 | $217.20 | |
| 87149 | <1% | 12 | $191.98 | |
| 84146 | <1% | 12 | $184.97 | |
| 96380 | <1% | 14 | $182.02 | |
| 91318 | <1% | 13 | $162.90 | |
| 91320 | <1% | 13 | $143.92 | |
| 36416 | <1% | 50 | $130.66 | |
| 87210 | <1% | 24 | $127.56 | |
| 84100 | <1% | 26 | $117.84 | |
| 90660 | <1% | 44 | $108.99 | |
| 83690 | <1% | 30 | $98.48 | |
| 81015 | <1% | 30 | $60.30 | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 28 | $57.09 |
| 98967 | <1% | 15 | $49.49 | |
| 93321 | <1% | 12 | $46.00 | |
| 93294 | <1% | 14 | $31.20 | |
| 85018 | <1% | 12 | $29.88 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 39 | $23.65 |
| 93325 | <1% | 12 | $19.65 | |
| Q9992 | Injection, buprenorphine extended-release (sublocade), greater than 100 mg | <1% | 31 | $0.26 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 13 | $0.05 |
| 3074F | 0% | 3,341 | $0.00 | |
| 3044F | 0% | 254 | $0.00 | |
| 98943 | 0% | 785 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 26 | $0.00 |
| 3079F | 0% | 111 | $0.00 | |
| 99406 | 0% | 157 | $0.00 | |
| 99417 | Prolong home eval add 15m | 0% | 25 | $0.00 |
| 1125F | 0% | 36 | $0.00 | |
| 1126F | 0% | 12 | $0.00 | |
| 1123F | 0% | 13 | $0.00 | |
| 1159F | 0% | 8,443 | $0.00 | |
| 1160F | 0% | 6,171 | $0.00 | |
| 99072 | 0% | 12,535 | $0.00 | |
| 3078F | 0% | 2,369 | $0.00 | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 0% | 55 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLOOMIS, ANNA (SR VP-CHIEF FINANCIAL OFFICE)
| Provider | Location | Paid |
|---|---|---|
| Multicare Health System | Puyallup, WA | $21.15M |
| Multicare Health System | Olympia, WA | $1.59M |
| Multicare Health System | Tacoma, WA | $1.09M |
| Multicare Health System | Lakewood, WA | $928K |
| Multicare Health System | Tacoma, WA | $784K |
| Multicare Health System | Auburn, WA | $404K |
| Legacy Visiting Nurse Association | Tualatin, OR | $102K |
| Silverton Health | Silverton, OR | $49K |
| Silverton Health | Molalla, OR | $9K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.